Skip to content
Screener

D&A at other companies

Eli Lilly logo
Eli LillyLLY
$534M+11.7%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$202K+46.4%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$295M-3.3%

Segments

By segment

See full
Reportable Segment$2.94M-9.4%

Other financials

Income statement

See full
Revenue$42.9M-2.5%
Gross profit$26.3M-1.8%
Operating income-$29.0K-104%
Net income-$1.1M-88.2%
EPS (diluted)-$0.02-100%

Balance sheet

See full
Cash & equivalents$18.8M+130%
Total debt$70.5M-17.4%
Total equity$104.8M+16.4%
Total assets$193.3M-2.6%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$228.0K-14.0%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$194M-50.2%
Enterprise value$245.64M-47.4%
P/S1.3×-1.1×

Profitability

See full
Gross margin59.7%+0.6pp
Operating margin-8.4%+14.7pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.3×
Current ratio0.8×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: AirSculpt Technologies, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 9:37 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001870940-26-000038
(in $000s, except for shares and per share figures)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Operating expenses:
Cost of service (exclusive of depreciation and amortization)16,56717,20132,15533,151
Selling, general and administrative23,42122,67146,00344,439
Depreciation and amortization2,9413,2465,9626,488
Loss on impairment of long-lived assets108108
Total operating expenses42,92943,22684,12084,186
(Loss)/income from operations(29)786(1,831)(803)
Interest expense, net1,0431,5622,2413,187

Item 1. Financial Statements

FAQ

What is AirSculpt Technologies, Inc.'s D&A?
AirSculpt Technologies, Inc. (AIRS) reported D&A of $2.94M in Q2 2026.
How has AirSculpt Technologies, Inc.'s D&A changed year-over-year?
AirSculpt Technologies, Inc.'s D&A decreased by 9.4% year-over-year, from $3.25M to $2.94M.
What is the long-term trend for AirSculpt Technologies, Inc.'s D&A?
Over 4 years (2021 to 2025), AirSculpt Technologies, Inc.'s D&A has grown at a 18.0% compound annual growth rate (CAGR), from $6.6M to $12.78M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ask your AI about AirSculpt Technologies, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude